Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 534
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 151–160 of 160 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04223024	Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma	active not recruiting	Phase 2	246	Sun Yat-sen UniversityOTHER	1	Mar 5, 2025	clinicaltrials
NCT04843098	Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma	active not recruiting	Phase 1 / Phase 2	108	Suzhou Junde Biotechnology Co., LtdINDUSTRY	1	Dec 9, 2024	clinicaltrials